Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Benjamin L. Ebert, Michael C. Kann et al.|Science Translational Medicine|2021Cited by 257
Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsisRebecca M. Baron, Mark A. Perrella, Min-Young Kwon et al.|Journal of Leukocyte Biology|2018Cited by 14
Mesenchymal stromal cells expressing a dominant-negative high mobility group A1 transgene exhibit improved function during sepsisMin‐Young Kwon, Mark A. Perrella, Sailaja Ghanta et al.|Journal of Leukocyte Biology|2021Cited by 4
Role Of High Mobility Group A1 Protein In Mesenchymal Cells During Sepsis In MiceAna P. Castaño, Mark A. Perrella, Rebecca M. Baron|Unknown|2012Cited by 0
Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen ReceptorsMax Jan, Benjamin L. Ebert, Ana P. Castaño et al.|Blood|2019Cited by 0